Skip to main content

Advertisement

SpringerLink
Log in

Treatment of Overactive Bladder in the Frail Patient

  • Overactive Bladder (U Lee and S Adelstein, Section Editors)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To understand how frailty interacts with overactive bladder. To explore how frailty should be considered when devising an individualized treatment plan for OAB patients.

Recent Findings

Frailty can be assessed in the outpatient office without undue burden. The urology community is increasingly aware of the importance of evaluating a patient for frailty and including this assessment in treatment algorithms. Frailty should be considered when treating OAB patients, since frail OAB patients are more susceptible to the potential deleterious consequences of medical therapy, onabotulinumtoxinA therapy, and sacral neuromodulation.

Summary

A patient’s frailty status should be considered during counseling regarding OAB therapy. Additional studies are needed to examine the treatment effects and risks in the frail OAB population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Cardona-Grau D, Spettel S. History of the term “overactive bladder”. Curr Bladder Dysfunct Rep. 2014;9:48–51. https://doi.org/10.1007/s11884-013-0218-3.

    Article  Google Scholar 

  2. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (AUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20. https://doi.org/10.1002/nau.20798.

    Article  PubMed  Google Scholar 

  3. Ninomiya S, Naito K, Nakanishi K, Okayama H. Prevalence and risk factors of urinary incontinence and overactive bladder in Japanese women. Low Urin Tract Symptoms. 2018;10(3):308–14. https://doi.org/10.1111/luts.12185.

    Article  PubMed  Google Scholar 

  4. Kim DY, Jang DH, Kim HJ, Lee SR, Jeon MJ, Shin JH, et al. A multicenter cross-sectional study on the prevalence of overactive bladder and its impacts on the quality of life in gynecologic outpatients. Obstet Gynecol Sci. 2020;63:181–6. https://doi.org/10.5468/ogs.2020.63.2.181.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–15. https://doi.org/10.1016/j.eururo.2006.09.019.

    Article  PubMed  Google Scholar 

  6. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327–36. https://doi.org/10.1007/s00345-002-0301-4.

    Article  CAS  PubMed  Google Scholar 

  7. Coyne KS, Sexton CC, Clemens JQ, Thompson CL, Chen C, Bavendam T, et al. The impact of OAB on physical activity in the United States: results from OAB-POLL. Urology. 2013;82:799–806. https://doi.org/10.1016/j.urology.2013.05.035.

    Article  PubMed  Google Scholar 

  8. Kinsey D, Pretorius S, Glover L, Alexander T. The psychological impact of overactive bladder: a systematic review. J Health Psychol. 2016;21:69–81. https://doi.org/10.1177/1359105314522084.

    Article  PubMed  Google Scholar 

  9. Coyne KS, Sexton CC, Thompson CL, Clemens JQ, Chen C, Bavendam T, et al. Impact of overactive bladder on work productivity. Urology. 2012;80:97–103. https://doi.org/10.1016/j.urology.2012.03.039.

    Article  PubMed  Google Scholar 

  10. Milson I, Kaplan SA, Conyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression and treatment seeking in the United States: results from EpiLUTS. Urology. 2012;80:90–6. https://doi.org/10.1016/j.urology.2012.04.004.

    Article  Google Scholar 

  11. Reynolds WS, Fowke J, Dmochowski R. The burden of overactive bladder on US public health. Curr Bladder Dysfunct Rep. 2016;11:8–13. https://doi.org/10.1007/s11884-016-0344-9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Suskind AM, Walter LC, Jin C, Boscardin J, Sen S, Cooperberg MR, et al. Impact of frailty on complications in patients undergoing common urological procedures: a study from the American College of Surgeons National Surgical Quality Improvement database. BJU Int. 2016;117:836–42. https://doi.org/10.1111/bju.13399.

    Article  PubMed  PubMed Central  Google Scholar 

  13. •• Suskind AM, Zhao S, Walter LC, Boscardin JW, Finlayson E. Mortality and functional outcomes after minor urologic surgery among nursing home residents: a national study. J Am Geriatr Soc. 2018;66:909–15. https://doi.org/10.1111/jgs.15302This retrospective cohort study demonstrated significant functional impairment and mortality rates in elderly, nursing home patients following simple urologic surgeries, which was previously not quantified. Authors concluded that this is a vulnerable population requiring improved treatment decision making processes.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193:1572–80. https://doi.org/10.1016/j.uro.2015.01.087.

    Article  PubMed  Google Scholar 

  15. Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, et al. Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score. Urology. 2006;68:318–23. https://doi.org/10.1016/j.urology.2006.02.042.

    Article  PubMed  Google Scholar 

  16. Chow WB, Rosenthal RA, Merkow RP, Yo CY, Esnaola NF. Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg. 2012;215:453–66. https://doi.org/10.1016/j.jamcollsurg.2012.06.017.

    Article  PubMed  Google Scholar 

  17. Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281–4.

    Article  Google Scholar 

  18. Hackett NJ, De Oliveira GS, Jain UK, Kim JYS. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int J Surg. 2015;18:184–90. https://doi.org/10.1016/j.ijsu.2015.04.079.

    Article  PubMed  Google Scholar 

  19. Amin KA, Lee UJ, Jin C, Boscardin J, Medendorp AR, Anger JT, et al. A national study demonstrating the need for improved frailty indices for preoperative risk assessment of common urologic procedures. Urology. 2019;132:87–93. https://doi.org/10.1016/j.urology.2019.07.001.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Scie Med Sci. 2001;56:M146–57. https://doi.org/10.1093/gerona/56.3.m146.

    Article  CAS  Google Scholar 

  21. Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8. https://doi.org/10.1111/j.1532-5415.1991.tb01616.x.

    Article  CAS  PubMed  Google Scholar 

  22. • Pangilinan J, Quanstrom K, Bridge M, Walter LC, Finlyason E, Suskind AM. The Timed Up and Go Test as a measure of frailty in urologic practice. Urology. 2017;106:32–8. https://doi.org/10.1016/j.urology.2017.03.054Researchers demonstrate the successful incorporation of the Timed Up and Go Test as an indicator of patient frailty for potential operative planning in their urologic practice. While there was no difference in frailty measures in patients undergoing operative versus nonoperative management, they acknowledged the role for frailty indices in treatment planning.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489–95. https://doi.org/10.1503/cmaj.050051.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Amin KA, Lee W, Moskowitz D, Kobashi KC, Lucioni A, Reed MJ, et al. A rapid method to preoperatively assess frailty for older patients with pelvic floor conditions. J Urol. 2020;203:1172–7. https://doi.org/10.1097/JU.0000000000000739.

    Article  PubMed  Google Scholar 

  25. •• Suskind AM, Quanstrom K, Zhao S, Bridge M, Walter LC, Neuhaus J, et al. Overactive bladder is strongly associated with frailty in older individuals. Urology. 2017;106:26–31. https://doi.org/10.1016/j.urology.2017.03.058This prospective study aimed to elucidate the complex relationship between advanced age, frailty and overactive bladder. They demonstrated that overactive bladder is strongly associated with frailty, as measured in the office with a Timed Up and Go Test, rather than increasing age.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Omae K, Yamamoto Y, Kurita N, Takeshima T, Naganuma T, Takahashi S, et al. Gait speed and overactive bladder in the healthy community-dwelling super elderly: the Sukagawa Study. Neurourol Urodyn. 2019;38:2324–32. https://doi.org/10.1002/nau.24148.

    Article  PubMed  Google Scholar 

  27. Wolff GF, Kuchel GA, Smith PP. Overactive bladder in the vulnerable elderly. Res Rep Urol. 2014;6:131–8. https://doi.org/10.2147/RRU.S41843.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Talley KMC, Wyman JF, Bronas U, Olson-Kellogg BJ, McCarthy TC. Defeating urinary incontinence with exercise training: results of a pilot study in frail older women. J Am Geriatr Soc. 2017;65:1321–7. https://doi.org/10.1111/jgs.14798.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Jensen J, Ludin-Olsson L, Nyberg L, Gustafson Y. Falls among frail older people in residential care. Scand J Public Health. 2002;30:54–61. https://doi.org/10.1177/14034948020300011201.

    Article  PubMed  Google Scholar 

  30. Lichetenstein AH, Rasmussen H, Yu WW, Epstein SR, Russell RM. Modified MyPyramid for older adults. J Nutr. 2008;138:5–11. https://doi.org/10.1093/jn/138.1.5.

    Article  Google Scholar 

  31. Picetti D, Foster S, Pangle AK, Schrader A, George M, Wei JY, et al. Hydration health literacy in the elderly. Nutr Healthy Aging. 2017;4:227–37. https://doi.org/10.3233/NHA-170026.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lindeman RD, Romero LJ, Liang HC, Baumgartner RN, Koehler KM, Garry PJ. Do elderly persons need to be encouraged to drink more fluids? J Gerontol A Biol Sci Med Sci. 2000;55:M361–5. https://doi.org/10.1093/gerona/55.7.m361.

    Article  CAS  PubMed  Google Scholar 

  33. • Suskind AM. The aging overactive bladder: a review of aging-related changes from the brain to the bladder. Curr Bladder Dysfunt Rep. 2017;12:42–7. https://doi.org/10.1007/s11884-017-0406-7The prevalence of overactive bladder increases with age, but the pathophysiology of this relationship is murky. This review article used new functional magnetic resonance imaging (fMRI) data to suggest that OAB development is likely related to the complex multifactorial interaction of physiologic decline in the bladder as well as the brain, ultimately pathologically influencing the micturition reflex.

    Article  Google Scholar 

  34. Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc. 2000;48:370–4. https://doi.org/10.1111/j.1532-5415.2000.tb04692.x.

    Article  CAS  PubMed  Google Scholar 

  35. Mansfield KJ, Liu L, Mitchelson FJ, Moore KH, Millard RJ, Burcher E. Muscarinic receptor subtypes in human bladder detrusor and nucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol. 2005;144:1089–99. https://doi.org/10.1038/sj.bjp.0706147.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia. JAMA Intern Med. 2019;179:1084–93. https://doi.org/10.1001/jamainternmed.2019.0677.

    Article  PubMed Central  Google Scholar 

  37. Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson’s disease related to antimuscarinic drugs. Ann Neurol. 2003;54:235–8. https://doi.org/10.1002/ana.10639.

    Article  CAS  PubMed  Google Scholar 

  38. Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong Anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175:401–7. https://doi.org/10.1001/jamainternmed.2014.7663.

    Article  PubMed  PubMed Central  Google Scholar 

  39. •• Welk B, McArthur E. Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study. BJU Int. 2020;126:183–90. https://doi.org/10.1111/bju.15040This matched retrospective cohort study demonstrated an increased risk of new onset dementia in patients taking an anticholinergic medication when compared to a beta-3 agonist. Notably, this study was conducted in first time users of anticholinergics, seemingly eliminating protocol bias seen in previous studies.

    Article  CAS  PubMed  Google Scholar 

  40. Liu YP, Chien WC, Chung CH, Chang HA, Kao YC, Tzeng NS. Are anticholingergic medications associated with increased risk of dementia and behavioral and psychological symptoms of dementia? A nationwide 15-year follow-up cohort study in Taiwan. Front Pharmacol. 2020;11:30. https://doi.org/10.3389/fphar.2020.00030.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Kay GG, Abou-Donia MB, Messer WS, Murphy DG, Tsao JW, Ouslander JG. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc. 2005;53:2195–201. https://doi.org/10.1111/j.1532-5415.2005.00537.x.

    Article  PubMed  Google Scholar 

  42. Geller EJ, Dumond JB, Bowling JM, Khandelwal CM, Wu JM, Busby-Whitehead J, et al. Effect of trospium chloride on cognitive function in women aged 50 and older: a randomized trial. Female Pelvic Med Reconstr Surg. 2017;2017(23):118–23. https://doi.org/10.1097/SPV.0000000000000374.

    Article  Google Scholar 

  43. Kosilov K, Kuzina I, Loparev S, Gainullina Y, Kosilova L, Prokofyeva A. Influence of the short-term intake of high doses of solifenacin and trospium on cognitive function and health-related quality of life in older women with urinary incontinence. Int Neurourol J. 2018;22:41–50. https://doi.org/10.5213/inj.1834996.498.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Wagg A, Dale M, Tretter R, Stow B, Compion G. Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study. Eur Urol. 2013;64:74–81. https://doi.org/10.1016/j.eururo.2013.01.002.

    Article  CAS  PubMed  Google Scholar 

  45. Pagoria D, O’Connor RC, Guralnick ML. Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients. Curr Urol Rep. 2011;12:351–7. https://doi.org/10.1007/s11934-011-0198-9.

    Article  PubMed  Google Scholar 

  46. Fick DM, Semla TP, Steinman M, Beizer J, Brandt N, Dombrowski R, et al. Updated AGS beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;2019(67):674–94. https://doi.org/10.1111/jgs.15767.

    Article  Google Scholar 

  47. Sink KM, Thomas J, Xu H, Craig B, Kritchevsky S, Sands LP. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc. 2008;56:847–53. https://doi.org/10.1111/j.1532-5415.2008.01681.x.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Deeks ED. Mirabegron: a review in overactive bladder syndrome. Drugs. 2018;78:833–44. https://doi.org/10.1007/s40265-018-0924-4.

    Article  CAS  PubMed  Google Scholar 

  49. •• Wagg A, Staskin D, Engel E, Herschorn S, Kristy RM, Schermer CR. Efficacy, safety and tolerability of mirabegron in patients aged >65 yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR). Eur Urol. 2020;77:211–20. https://doi.org/10.1016/j.eururo.2019.10.002Researchers examined the safety profile of mirabegron in patients over the age of 65, which is patient population previously unstudied for this medication. Patients reported significant improvement in voiding symptoms with minimal adverse side effects and notably, no change in cognitive impairment.

    Article  CAS  PubMed  Google Scholar 

  50. Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J. Polypharmacy and frailty: prevalence, relationship and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf. 2015;24:637–46. https://doi.org/10.1002/pds.3772.

    Article  PubMed  Google Scholar 

  51. Gutierrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero A, Inzitari M, Martinez-Velilla N. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84:1432–44. https://doi.org/10.1111/bcp.13590.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Liao CH, Kuo HC. Increased risk of large post-void residual urine and decreased long-term success rate after intravesical onabotulinumtoxinA injection for refractory idiopathic detrusor overactivity. J Urol. 2013;189:1804–10. https://doi.org/10.1016/j.juro.2012.11.089.

    Article  CAS  PubMed  Google Scholar 

  53. Kuo HC, Liao CH, Chung SD. Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome. Eur Urol. 2010;58:919–26. https://doi.org/10.1016/j.eururo.2010.09.007.

    Article  CAS  PubMed  Google Scholar 

  54. • Greenberg DR, Syan R, Young-Lin N, Comiter CV, Enemchukwu E. Outcomes of sacral nerve stimulation for treatment of refractory overactive bladder among octogenarians. Neuromodulation. 2019;22:738–44. https://doi.org/10.1111/ner.12981This retrospective review is one of the first to demonstrate the efficacy of sacral nerve stimulation (SNS) in patients over the age of 80 with overactive bladder, which is significant as older age is often cited as a reason to avoid this treatment modality.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, PA, 19107, USA

    Sage Vincent, Anthony Tokarski & Alana Murphy

Authors
  1. Sage Vincent
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony Tokarski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alana Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alana Murphy.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Overactive Bladder

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vincent, S., Tokarski, A. & Murphy, A. Treatment of Overactive Bladder in the Frail Patient. Curr Bladder Dysfunct Rep 15, 386–392 (2020). https://doi.org/10.1007/s11884-020-00621-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-020-00621-0

Keywords

Search

Navigation